Abstract
Pacific Islander (PI) women experience disproportionately high rates of cervical cancer and mortality and have lower rates of Pap testing. Since up to 70% of cervical cancers could be prevented by being vaccinated for human papilloma virus (HPV), this cross-sectional study explored the predictors of HPV and vaccine awareness, receipt of the vaccine, and attitudes toward vaccinating children among adult PI women in southern California, who historically have low rates of HPV vaccination and high rates of cervical cancer that could be prevented with HPV vaccination. Participants (n=148) consist a subsample of Chamorro, Samoan, and Tongan women, ages 21 to 65 years, who were in a larger randomized community study to promote Pap testing. Overall, younger age and higher American acculturation were significantly associated with ever hearing about HPV and the vaccine. However, American acculturation was also associated with negative attitudes toward vaccinating their children for HPV. This paper provides preliminary insights into barriers and facilitators to HPV vaccination among PIs in the USA and also informs the development of educational programs to reduce cervical cancer incidence and mortality in this underserved population.
Similar content being viewed by others
References
Miller BA, Chu KC, Hankey BF, Ries LAG (2008) Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control 19:227–256
AAAJ (2014) A community of contrasts: native Hawaiians and Pacific Islanders in California. Justice AAA, Los Angeles
Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER (2013) Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 208:385–393
Ault KA (2007) Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in site: a combined analysis of four randomized clinical trials. Lancet 369(9576):1861–1868
Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S (2019) National, regional, state, and selected local area vaccination coverage among adolescents Aged 13–17 Years — United States, 2018. MMWR Morb Mortal Wkly Rep 68:718–723
Schisler TM, Bhavsar AK, Whitcomb BP, Freeman JH, Washington MA, Blythe JW, Nahid MA, Dietrich CS (2018) Human papilloma virus genotypes in Pacific Islander cervical cancer patients. Gynecol Oncol. Case Rep 24:83–86
UCLA. 2007. California health interview survey: adult questionnaire 2005. UCLA Center for Health Policy Research.
DiStefano AS, Hui B, Barrera-Ng A, Quitugua LF, Peters R, Dimaculangan J, Vunileva I, Tui’one V, Takahashi LM, Tanjasiri SP (2012) Contextualization of HIV and HPV risk and prevention among Pacific Islander young adults in Southern California. Soc Sci Med 75:699–708
Kepka D, Bodson J, Lai D, Sanchez-Birkhead AC, Davis FA, Lee D, Tavake-Pasi F, Napia E, Villalta J, Mukundente V, Mooney R, Coulter H, Stark LA. 2018. Diverse caregivers’ HPV vaccine-related awareness and knowledge. Ethn Health 1-16. DOI: https://doi.org/10.1080/13557858.2018.1562052.
Tanjasiri SP, Mouttapa M, Sablan-Santos L, Weiss JW, Chavarria A, Lacsamana JD, May VT, Quitugua L, Tupua M, Schmidt-Vaivao D (2019) Design and outcomes of a community trial to increase Pap testing in Pacific Islander women. Cancer Epidemiol Biomarkers Prev 28:1435–1442
Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (2019) Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. Am J Transplant 19:3202–3206
CDC. 2019. Evidence to recommendations for HPV vaccination of adults 27-45 years old. www.cdc.gov/vaccines/acip/recs/grade/HPV-adults-etr.html. Accessed January 16, 2020.
Kaholokula JK, Nacapoy AH, Grandinetti A, Chang HK (2008) Association between acculturation modes and type 2 diabetes among Native Hawaiians. Diabetes Care 31:698–700
Tanjasiri SP, Mouttapa M, Sablan-Santos L, Quitugua LF (2012) What promotes cervical cancer screening among Chamorro women in California? J Cancer Educ 27:725–730
Dang J, Lee J, Tran JH (2010) Knowledge, attitudes, and beliefs regarding breast and cervical cancer screening among Cambodian, Laotian, Thai, and Tongan women. J Cancer Educ 25:595–601
UCLA. 2007. California health interview survey: adult questionnaire 2007. UCLA Center for Health Policy Research.
Hosmer DW, Lemeshow S (2000) Applied Lostistic Regression, 2nd edn. John Wiley & Sons, Inc., New York
Bendel R, Afifi A (1977) Comparison of stopping rules in forward “stepwise” regression. J Am Statistial Assoc 72:46–53
Yi JK, Lackey SC, Zahn MP, Castaneda J, Hwang JP (2013) Human papillomavirus knowledge and awareness among Vietnamese mothers. J Community Health 38:1003–1009
Berezin M, Eads A (2016) Risk is for the rich? Childhood vaccination resistance and a culture of health. Soc Sci Med 165:233–245
Vanderpool RC, Dressler EV, Stradtman LR, Crosby RA (2015) Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women. J Rural Health 31:199–205
Stupiansky NW, Zimet GD, Cummings T, Fortenberry JD, Shew M (2012) Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. J Adolesc Health 50:103–105
Santhanes D, Wong CP, Yap YY, San SP, Chaiyakunapruk N, Khan TM (2018) Factors involved in human papillomavirus (HPV) vaccine hesitancy among women in the South-East Asian Region (SEAR) and Western Pacific Region (WPR): a scoping review. Hum Vaccin Immunother 14:124–133
Acknowledgements
The authors recognize the following individuals for their contributions to the longitudinal study:
Jie W. Weiss, Lola Santos, Peter Flores, Preciosa Flores, Ualania Ho`opai, Jasmine Deguzman Lacsamana, Genesis Lutu, Darlene March, Noelle Moananu, Ciara Paige, Lourdes Quitugua, Peniamina Taito, Vanessa Tui’one May, Alisi Tulua, Marina Tupua, Elenoa Vaikona, Dorothy Vaivao, Isileli Vunileva, and all the members of the Community Advisory Board.
Availability of data and material
In accordance with NIH recommendations, de-identified data for this study can be made available upon request.
Code availability
All analyses were conducted using SPSS, version 25. No custom codes were used to conduct the analyses.
Funding
This project was funded by the National Cancer Institute’s Center to Reduce Cancer Health Disparities (grant number R01CA149324).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study presented in this manuscript was approved by the Institutional Review Board at California State University, Fullerton prior to implementation. At the time of recruitment, the research team explained to the participants, in person, the purpose of the study. Participants also received an informed consent form document, which they had time to review. Participants then provided their written consent on the last page of the informed consent form prior to answering survey questions.
Consent for publication
The consent form that participants sign indicates that the results from this study could be used for research purposes in the future, including peer-reviewed conference presentations and publications.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mouttapa, M., Cunningham, M. & Tanjasiri, S.P. Awareness of and Support for HPV Vaccination Among Pacific Islander Women in Southern California. J Canc Educ 37, 1372–1377 (2022). https://doi.org/10.1007/s13187-021-01965-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-021-01965-9